Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$275.25 - $318.06 $12.7 Million - $14.7 Million
-46,300 Reduced 26.61%
127,722 $36.4 Million
Q1 2023

Aug 11, 2023

BUY
$256.56 - $292.34 $44.6 Million - $50.9 Million
174,022 New
174,022 $48.4 Million
Q4 2022

Aug 11, 2023

BUY
$252.44 - $306.72 $43.9 Million - $53.4 Million
174,022 New
174,022 $48.2 Million
Q2 2022

Aug 12, 2022

BUY
$187.54 - $223.02 $281,310 - $334,530
1,500 Added 0.9%
167,922 $34.2 Million
Q4 2021

Jan 25, 2022

SELL
$223.92 - $287.77 $20 Million - $25.7 Million
-89,200 Reduced 34.9%
166,422 $39.9 Million
Q3 2021

Oct 26, 2021

BUY
$282.99 - $369.05 $3 Million - $3.91 Million
10,600 Added 4.33%
255,622 $72.3 Million
Q2 2021

Jul 23, 2021

SELL
$259.0 - $414.71 $1.01 Million - $1.62 Million
-3,900 Reduced 1.57%
245,022 $84.8 Million
Q1 2021

May 14, 2021

SELL
$242.95 - $284.63 $23.2 Million - $27.1 Million
-95,354 Reduced 27.7%
248,922 $69.6 Million
Q4 2020

Feb 08, 2021

BUY
$236.26 - $355.63 $732,406 - $1.1 Million
3,100 Added 0.91%
344,276 $84.3 Million
Q3 2020

Oct 29, 2020

BUY
$264.77 - $305.71 $2.12 Million - $2.45 Million
8,000 Added 2.4%
341,176 $96.8 Million
Q2 2020

Jul 22, 2020

BUY
$258.66 - $342.55 $13.1 Million - $17.4 Million
50,700 Added 17.95%
333,176 $89.1 Million
Q1 2020

Apr 22, 2020

BUY
$268.85 - $341.04 $2.8 Million - $3.55 Million
10,400 Added 3.82%
282,476 $89.4 Million
Q4 2019

Feb 03, 2020

BUY
$220.06 - $304.07 $3.69 Million - $5.09 Million
16,755 Added 6.56%
272,076 $80.7 Million
Q3 2019

Oct 24, 2019

BUY
$217.44 - $243.88 $27.8 Million - $31.2 Million
127,895 Added 100.37%
255,321 $59.4 Million
Q2 2019

Oct 03, 2019

BUY
$219.29 - $241.72 $27.9 Million - $30.8 Million
127,426 New
127,426 $29.8 Million
Q2 2019

Jul 16, 2019

SELL
$219.29 - $241.72 $33.1 Million - $36.5 Million
-151,003 Closed
0 $0
Q1 2019

Oct 03, 2019

BUY
$216.71 - $338.96 $32.7 Million - $51.2 Million
151,003 New
151,003 $35.7 Million
Q1 2019

Apr 08, 2019

SELL
$216.71 - $338.96 $21.4 Million - $33.5 Million
-98,727 Closed
0 $0
Q4 2018

Oct 03, 2019

BUY
$278.5 - $352.75 $27.5 Million - $34.8 Million
98,727 New
98,727 $29.7 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Railway Pension Investments LTD Portfolio

Follow Railway Pension Investments LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Railway Pension Investments LTD, based on Form 13F filings with the SEC.

News

Stay updated on Railway Pension Investments LTD with notifications on news.